Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Materion (MTRN)

Materion swings to Q4 net loss of $48.8 million; record adjusted EBITDA of $61.5 million

Mixed Impact 3 of 5 earnings Written later

Materion reported fourth quarter and full-year 2024 results on February 19, 2025, and gave 2025 adjusted earnings guidance of $5.30 to $5.70 per share. The fourth quarter net loss reflected $82.0 million of special items, including $73.2 million of Precision Optics impairments, while adjusted EBITDA reached a quarterly record. Full-year GAAP net income fell to $5.9 million from $95.7 million, and shareholders should weigh the large charges against the stronger operating measures.

Key points

  • Q4 2024 net loss of $48.8 million, or $2.33 per diluted share, versus net income of $19.5 million, or $0.93, a year earlier
  • Q4 2024 adjusted EBITDA of $61.5 million, a quarterly record, versus $53.3 million; full-year 2024 net income of $5.9 million, or $0.28 per diluted share, versus $95.7 million
  • 2025 adjusted earnings guidance of $5.30 to $5.70 per diluted share, about 3% higher than 2024 at the midpoint; new mid-term adjusted EBITDA margin target of 23%

The filing

CompanyMaterion (MTRN)
Form8-K, current report
Filed with the SECFeb 19, 2025, 6:49 AM ET
Accession number0001104657-25-000019

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.